Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions

Circulation. 2011 May 31;123(21):2414-22. doi: 10.1161/CIRCULATIONAHA.110.012781.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Black or African American / genetics
  • Clinical Trials, Phase I as Topic / trends
  • Clinical Trials, Phase II as Topic / trends
  • Exercise Tolerance / drug effects
  • Exercise Tolerance / physiology
  • Forecasting
  • Heart Failure / drug therapy*
  • Heart Failure / genetics
  • Heart Failure / physiopathology
  • Humans
  • Hydralazine / pharmacology
  • Hydralazine / therapeutic use*
  • Isosorbide Dinitrate / pharmacology
  • Isosorbide Dinitrate / therapeutic use*
  • Stroke Volume / drug effects
  • Stroke Volume / physiology

Substances

  • Hydralazine
  • Isosorbide Dinitrate